References
1 Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. PMID: 26903338. PMCID: PMC4968574. DOI: 10.1001/jama.2016.0287.
2 Iba T, Levy JH. Sepsis-induced coagulopathy and disseminated intravascular coagulation[J]. Anesthesiology, 2020, 132(5): 1238-1245. PMID: 32044801. DOI: 10.1097/ALN.0000000000003122.
3 Iba T, Nisio MD, Levy JH, et al. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey[J]. BMJ Open, 2017, 7(9): e017046. PMID: 28963294. PMCID: PMC5623518. DOI: 10.1136/bmjopen-2017-017046.
4 Abe T, Kubo K, Izumoto S, et al. Complement activation in human sepsis is related to sepsis-induced disseminated intravascular coagulation[J]. Shock, 2020, 54(2): 198-204. PMID: 31917735. DOI: 10.1097/SHK.0000000000001504.
5 Xie K, Kong S, Li F, et al. Bioinformatics-based study to investigate potential differentially expressed genes and miRNAs in pediatric sepsis[J]. Med Sci Monit, 2020, 26: e923881. PMID: 32575108. PMCID: PMC7331480. DOI: 10.12659/MSM.923881.
6 Sauter RJ, Sauter M, Reis ES, et al. Functional relevance of the anaphylatoxin receptor C3aR for platelet function and arterial thrombus formation marks an intersection point between innate immunity and thrombosis[J]. Circulation, 2018, 138(16): 1720-1735. PMID: 29802205. PMCID: PMC6202244. DOI: 10.1161/CIRCULATIONAHA.118.034600.
7 Schmidt CQ, Schrezenmeier H, Kavanagh D. Complement and the prothrombotic state[J]. Blood, 2022, 139(13): 1954-1972. PMID: 34415298. DOI: 10.1182/blood.2020007206.
8 Abrams ST, Morton B, Alhamdi Y, et al. A novel assay for neutrophil extracellular trap formation independently predicts disseminated intravascular coagulation and mortality in critically ill patients[J]. Am J Respir Crit Care Med, 2019, 200(7): 869-880. PMID: 31162936. PMCID: PMC6812439. DOI: 10.1164/rccm.201811-2111OC.
9 中华医学会儿科学分会急救学组, 中华医学会急诊医学分会儿科学组, 中国医师协会儿童重症医师分会. 儿童脓毒性休克(感染性休克)诊治专家共识(2015版)[J]. 中华儿科杂志, 2015, 53(8): 576-580. PMID: 26717653. DOI: 10.3760/cma.j.issn.0578-1310.2015.08.007.
10 Schmoch T, M?hnle P, Weigand MA, et al. The prevalence of sepsis-induced coagulopathy in patients with sepsis: a secondary analysis of two German multicenter randomized controlled trials[J]. Ann Intensive Care, 2023, 13(1): 3. PMID: 36635426. PMCID: PMC9837358. DOI: 10.1186/s13613-022-01093-7.
11 de Bont CM, Boelens WC, Pruijn GJM. NETosis, complement, and coagulation: a triangular relationship[J]. Cell Mol Immunol, 2019, 16(1): 19-27. PMID: 29572545. PMCID: PMC6318284. DOI: 10.1038/s41423-018-0024-0.
12 Hayakawa M, Yamakawa K, Saito S, et al. Nationwide registry of sepsis patients in Japan focused on disseminated intravascular coagulation 2011-2013[J]. Sci Data, 2018, 5: 180243. PMID: 30531950. PMCID: PMC6289115. DOI: 10.1038/sdata.2018.243.
13 van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis[J]. Immunity, 2021, 54(11): 2450-2464. PMID: 34758337. DOI: 10.1016/j.immuni.2021.10.012.
14 van der Poll T, van de Veerdonk FL, Scicluna BP, et al. The immunopathology of sepsis and potential therapeutic targets[J]. Nat Rev Immunol, 2017, 17(7): 407-420. PMID: 28436424. DOI: 10.1038/nri.2017.36.
15 Mollnes TE, Huber-Lang M. Complement in sepsis-when science meets clinics[J]. FEBS Lett, 2020, 594(16): 2621-2632. PMID: 32621378. DOI: 10.1002/1873-3468.13881.
16 Wang Y, Liu W, Xu Y, et al. Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins[J]. Nat Chem Biol, 2023, 19(11): 1351-1360. PMID: 37169960. DOI: 10.1038/s41589-023-01339-w.
17 Thiam HR, Wong SL, Wagner DD, et al. Cellular mechanisms of NETosis[J]. Annu Rev Cell Dev Biol, 2020, 36: 191-218. PMID: 32663035. PMCID: PMC8499668. DOI: 10.1146/annurev-cellbio-020520-111016.
18 Varjú I, Longstaff C, Szabó L, et al. DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment[J]. Thromb Haemost, 2015, 113(6): 1289-1298. PMID: 25789443. DOI: 10.1160/TH14-08-0669.
19 Pieterse E, Rother N, Garsen M, et al. Neutrophil extracellular traps drive endothelial-to-mesenchymal transition[J]. Arterioscler Thromb Vasc Biol, 2017, 37(7): 1371-1379. PMID: 28495931. DOI: 10.1161/ATVBAHA.117.309002.
20 周利兵, 陈娇, 杜晓晨, 等. 探讨3种评分系统对儿童严重脓毒症预后的评估价值[J]. 中国当代儿科杂志, 2019, 21(9): 898-903. PMID: 31506150. PMCID: PMC7390254. DOI: 10.7499/j.issn.1008-8830.2019.09.011.
21 Propson NE, Roy ER, Litvinchuk A, et al. Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging[J]. J Clin Invest, 2021, 131(1): 140966. PMID: 32990682. PMCID: PMC7773352. DOI: 10.1172/JCI140966.
22 Alsabani M, Abrams ST, Cheng Z, et al. Reduction of NETosis by targeting CXCR1/2 reduces thrombosis, lung injury, and mortality in experimental human and murine sepsis[J]. Br J Anaesth, 2022, 128(2): 283-293. PMID: 34893315. PMCID: PMC8792833. DOI: 10.1016/j.bja.2021.10.039.
23 鲁海艳, 张高峰, 方长太, 等. 血清sTM、IL-6、PCT、E-选择素对脓毒症患者并发凝血功能异常的预测价值[J]. 山东医药, 2020, 60(17): 64-66. DOI: 10.3969/j.issn.1002-266X.2020.17.018.
24 俞秋兴, 张勇, 杜鸿, 等. 脓毒症患者中性粒细胞胞外诱捕网的定量研究[J]. 中华实验外科杂志, 2021, 38(11): 2216-2218. DOI: 10.3760/cma.j.cn421213-20210331-00273.
25 Yamakawa K, Yoshimura J, Ito T, et al. External validation of the two newly proposed criteria for assessing coagulopathy in sepsis[J]. Thromb Haemost, 2019, 119(2): 203-212. PMID: 30593085. DOI: 10.1055/s-0038-1676610.